Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 21.17% |
| Q2 2025 | 47.76% |
| Q1 2025 | -30.77% |
| Q4 2024 | 23.53% |
| Q3 2024 | 15.00% |
| Q2 2024 | 20.00% |
| Q1 2024 | 10.71% |
| Q4 2023 | -16.67% |
| Q3 2023 | 17.24% |
| Q2 2023 | 3.33% |
| Q1 2023 | 18.92% |
| Q4 2022 | -19.35% |
| Q3 2022 | 18.42% |
| Q2 2022 | 13.64% |
| Q1 2022 | -62.96% |
| Q4 2021 | 34.15% |
| Q3 2021 | -24.24% |
| Q2 2021 | 19.51% |
| Q1 2021 | -10.81% |
| Q4 2020 | -8.82% |
| Q3 2020 | 10.53% |
| Q2 2020 | 20.83% |
| Q1 2020 | -29.73% |
| Q4 2019 | -19.35% |
| Q3 2019 | 32.61% |
| Q2 2019 | 14.81% |
| Q1 2019 | 6.90% |
| Q4 2018 | 6.45% |
| Q3 2018 | -72.22% |
| Q2 2018 | 2.70% |
| Q1 2018 | 27.45% |
| Q4 2017 | -112.50% |
| Q3 2017 | -14.29% |
| Q2 2017 | -31.25% |
| Q1 2017 | -14.29% |
| Q4 2016 | -42.71% |
| Q3 2016 | 48.37% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |